BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 27696935)

  • 1. The evolution of recombinant thrombolytics: Current status and future directions.
    Adivitiya ; Khasa YP
    Bioengineered; 2017 Jul; 8(4):331-358. PubMed ID: 27696935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary embolism thrombolysis: Do we need another agent?
    Goldhaber SZ
    Am Heart J; 1999 Jul; 138(1 Pt 1):1-2. PubMed ID: 10385751
    [No Abstract]   [Full Text] [Related]  

  • 3. How should intravenous thrombolytic agents for acute myocardial infarction be selected?
    Topol EJ
    Cardiovasc Clin; 1990; 21(1):57-75; discussion 76-8. PubMed ID: 2143103
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombolytic therapy for acute myocardial infarction--round 2.
    Lancet; 1988 Mar; 1(8585):565-7. PubMed ID: 2894496
    [No Abstract]   [Full Text] [Related]  

  • 5. Importance of fibrin specificity in therapeutic thrombolysis and the rationale of using sequential and synergistic combinations of tissue plasminogen activator and pro-urokinase.
    Gurewich V
    Semin Thromb Hemost; 1989 Apr; 15(2):123-8. PubMed ID: 2501871
    [No Abstract]   [Full Text] [Related]  

  • 6. Additive fibrinolysis by recombinant tissue-type plasminogen activator (r-t-PA) and recombinant single-chain urokinase type plasminogen activator (r-scu-PA) in rabbit pulmonary thrombosis.
    Schneider J; Friderichs E; Günzler WA; Flohé L
    Thromb Res; 1989 Oct; 56(1):59-65. PubMed ID: 2512686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational initiatives in thrombolytic therapy.
    Klegerman ME
    Front Med; 2017 Mar; 11(1):1-19. PubMed ID: 28116631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.
    Ferres H
    Drugs; 1987; 33 Suppl 3():33-50. PubMed ID: 3315613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin-specific thrombolytic agents.
    Collen D
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1791-8. PubMed ID: 3122317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis.
    Ouriel K; Welch EL; Shortell CK; Geary K; Fiore WM; Cimino C
    J Vasc Surg; 1995 Nov; 22(5):593-7. PubMed ID: 7494361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term benefit of one thrombolytic over another.
    Grobman BJ
    Circulation; 1997 Sep; 96(6):2093. PubMed ID: 9323115
    [No Abstract]   [Full Text] [Related]  

  • 14. Liposomal nanocarriers for plasminogen activators.
    Koudelka S; Mikulik R; Mašek J; Raška M; Turánek Knotigová P; Miller AD; Turánek J
    J Control Release; 2016 Apr; 227():45-57. PubMed ID: 26876783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic therapy.
    Collen D; Stump DC; Gold HK
    Annu Rev Med; 1988; 39():405-23. PubMed ID: 3130773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local thrombolysis in peripheral arterial occlusion].
    Hess H
    Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The results of arterial thrombolysis.
    Kroese AJ; Staxrud LE
    Ann Chir Gynaecol; 1995; 84(4):350-3. PubMed ID: 8687078
    [No Abstract]   [Full Text] [Related]  

  • 19. [The choice of appropriate thrombolytic agents as therapy in acute heart infarct].
    Görge G; Meyer J
    Med Klin (Munich); 1992 Feb; 87(2):70-80, 108. PubMed ID: 1542286
    [No Abstract]   [Full Text] [Related]  

  • 20. [Development of new thrombolytic substances].
    Zeymer U; Neuhaus KL
    Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.